Please assess the completion status of the following clinical trial:

Trial Title: Observational Study of COVID-19 Treatment Efficacy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: OTHER
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* test positive for COVID-19~* be inpatient~* Have signs of respiratory distress = had either an SpO2 of less 95% or lower recorded or a respiratory rate RR \>20 (21 or more) recorded and \<60 (eliminate aberrant charting)~Exclusion Criteria:~* Age less than 18~* Currently actively in an investigational drug trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hydroxychloroquine - NO (Type: None): Did not receive / are not receiving any Hydroxychloroquine
- Hydroxychloroquine - YES - started before (Type: None): Hydroxychloroquine date started was before the date recorded for signs of respiratory distress
- Hydroxychloroquine - YES - started same (Type: None): Hydroxychloroquine date started was the same as the date recorded for signs of respiratory distress
- Hydroxychloroquine - YES - started after (Type: None): Hydroxychloroquine date started was after the date recorded for signs of respiratory distress

Based on this trial design, predict the completion outcome and termination type (if applicable).